Haemonetics Corporation (NYSE:HAE) went down by -1.32% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Medical Instruments & Supplies giant went up by $91.12 to trade ended Tuesday trading at $92.34. This is down from the $92.34 price recorded on Monday’s trading session. Thanks to this latest performance, HAE is closer to the higher price 52-week target of $165.00 and further from the lowest price target of $113.00. Its performance from the start of the year has also been negative, with HAE down by -20.70% year-to-date.
Haemonetics Corporation (HAE) started the day trading at $92.02 and recorded an intraday high of $92.51. It also recorded an intraday low of $91.05 during Tuesday’s trading session. Haemonetics Corporation is a very active stock that recorded a trading volume that is more than 1.23% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 680362, which is more than 1.23 of the total average daily trading volume of 671.96K.
Haemonetics Corporation (NYSE:HAE) 2020 Performance Impressive
The increase in HAE’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of HAE currently stands at $140.36, which is higher than the current trading price of the stock by 35.08%. However, HAE’s current trading price is -43.7% lower than the 52-week low price of $63.41. In terms of trading volume, Haemonetics Corporation currently experienced healthy participation during the last trading session. 680362 shares of Haemonetics Corporation were traded on the stock exchange on Tuesday, which is more than 1.23% of the 671.96K average trading volume of the stock.
The performance of the stock has been positive over the past year. HAE’s performance over the past one year has seen it plunge by -24.43%, while the stock has gone down by -21.14% in the last six months. The quarterly performance of HAE currently stands at -10.88%, and it is down by -8.04% in the last month. The only positive figure was from the weekly performance, which currently reads 3.56%. At the time of writing HAE’s report, the company has a total market cap of $4.45B, making it one of the largest publicly-traded companies in the world.Haemonetics Corporation also has over 3004 employees all over the world.
HAE Insider Activities
The insider transactions over the past six months are up by 17.50%.For Haemonetics Corporation insiders bought 206,726 shares in 19 transactions. In that same period, insiders sold 142,573 of their shares in 44 transactions. After these transactions, insiders at Haemonetics Corporation now hold 437.36k shares, which is over 101.86% of the total company stocks. Institutional investors currently hold a large chunk of the HAE shares, as they control 0.87% of the company’s total stock.
HAE Fundamental Analysis
For Haemonetics Corporation, the stock’s diluted earnings per share (EPS) stands at 1.48. In the coming year, analysts expect the EPS to be 4.04. The EPS growth will up over the next five years to 12.00% after surging by 35.40% in the previous five years. In terms of revenue, Haemonetics Corporation’s quarterly sales (YOY) is growing at 0.42, which is lower than the average annual revenue of 35.40% over the past half a decade.
The Return on Investment (ROI) on Haemonetics Corporation’s stock currently stands at 9.60%, and it has a net profit margin of 7.70%. The operating margin of the company is 10.50%, and its gross margin is 49.00%.
HAE Analysts Prediction
Barrington Research reiterate their Outperform position on the stock ($116 and $139)
Analysts at Barrington Research believe that HAE is Outperform, and they have a price target of between $112 and $116. HAE received a positive rating from Barrington Research, which set a price target of $90-$118 for the stock.
At the moment, Haemonetics Corporation’s Total Debt to Equity ratio stands at 0.65, and they have a long-term Debt to Equity ratio of 0.52.
HAE Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of HAE currently stands at 1.66%, while the SMA50 is -8.79%. The biggest one is the SMA200, which is currently reading -17.62% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 46.29, while its price to earnings ratio (P/E) is 61.69.